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Abstract: An alcohol dehydrogenase-mediated asymmetric reduction and subsequent intramolecular oxa-Michael reaction has 
been developed for the preparation of tetrahydropyrans (or oxanes) and tetrahydrofurans, in excellent conversion, yield and high 
enantiomeric and diastereomeric excess. To highlight the utility of the methodology,  we report the synthesis of an analogue of 
the fungal antioxidant brocaketone A. Also described is the preparation of the ()-(R,R)-enantiomer of the natural product, (+)-
(S,S)-(cis-6-methyltetrahydropyran-2-yl)acetic acid.  
The intramolecular oxa-Michael reaction (IMOMR) is a direct and rapid approach for carbon-oxygen bond 
formation, which allows the construction of synthetically useful cyclic oxygen-containing heterocycles.[1] In 
particular, the IMOMR is exploited as a key step in cascade strategies for the preparation of chiral 
tetrahydropyrans (THPs) and tetrahydrofurans (THFs), which are prevalent in natural products (Figure 1).[1d,2] 
The syntheses of these motifs often commence from the chiral pool, to provide the desired enantiomer of the 
nucleophilic alcohol, prior to the IMOMR. This chiral centre has also been installed via asymmetric catalysis but 
the scope of this chemistry is limited.[1c,1g, 2d]  
 A useful approach for the synthesis of THPs/THFs is represented in Scheme 1 and involves the chemo- and 
stereo-selective reduction of ketoenone 1, followed by a spontaneous IMOMR to afford oxa-Michael product 3. 
However, this strategy has a number of challenges (highlighted in blue), which would be difficult to overcome 
when using traditional reduction chemistry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A selection of tetrahydropyran and tetrahydrofuran-containing natural products. 
 
 
 
 
 
 
 
 
Scheme 1. A retrosynthetic approach for the synthesis of THP/THF derivatives starting from ketoenone 1. 
 
 The growing toolbox of biocatalysts, which can mediate synthetically challenging reactions and complement 
traditional chemical synthesis, has inspired the concept of biocatalytic retrosynthesis.[3] Incorporating enzymes 
into retrosynthetic design strategies enables completely new disconnections, which would not be feasible using 
more traditional synthetic approaches. We have previously reported a transaminase-triggered intramolecular 
aza-Michael reaction (IMAMR) for the synthesis of chiral 2,6-disubstituted piperidines,[4] and envisaged that an 
analogous approach could be used for the chemo-enzymatic synthesis of THPs/THFs, by employing an alcohol 
dehydrogenase (ADH). These enzymes have been heavily exploited for the selective reduction of prochiral 
ketones to afford the corresponding chiral alcohol. This methodology has been used both in vitro and in vivo, 
often in combination with a suitable co-factor recycling system.[5] ADHs are also used for the selective oxidation 
of primary or secondary alcohols, with the latter typically resulting in a kinetic resolution. [6]  
  Herein, we report an expansion of our aza-Michael methodology to include the biocatalytic ADH 
reduction/IMOMR cascade on a panel of prochiral keto-enone substrates. An (R)-selective ADH from 
Lactobacillus kefir (LK) DSM 20587 has been selected to showcase this methodology, due to its broad substrate 
specificity and high enantioselectivity in the synthesis of chiral alcohols, including dicarbonyl substrates.[7] 
 Ketoenone substrates 1a-c and 1e-i (Table 1) were prepared via oxidative cleavage of 1-methylcyclopentene 
or 6-methyl-5-hepten-2-one, followed by reaction with a suitable phosphorus ylid. Ketoenone 1d was prepared 
via an alternative strategy, starting from carboxylic acid 5 (Scheme 3). The biocatalytic reduction of dimethyl 
ketoenone 1a was initially examined, using LK-ADH in combination with a glucose dehydrogenase 
(GDH)/NADPH recycling system (Scheme 2).[7a] The unhindered methyl ketone and methyl enone make the 
regioselective reduction of 1a particularly challenging. We recently reported an analogous transaminase-
triggered IMAMR on this substrate, where despite a lack of regioselectivity, the reversibility of the 
biotransformation allows isolation of the desired product via a dynamic ‘shuttling’ mechanism.[4] However, it is 
not possible to exploit the same reversibility during the ADH reaction, and therefore regioselective reduction of 
the ketone over the enone is essential. After one hour, 1a was quantitatively converted to undesired diol 4a, 
using LK-ADH. Close monitoring of the biotransformation over time revealed that the desired IMOM precursor 
2a, along with a small quantity of THP 3a, is formed within approximately 8 minutes, in 82% conversion. This 
mixture can be fully converted to the desired cyclic product 3a by stirring in ethereal hydrogen chloride solution, 
to provide cis-3a, in 75% yield, as a 12:1 ratio of cis/trans isomers.[1h] Further incubation of the biotransformation 
led to a second undesired ADH-mediated reduction taking place, affording diol 4a. This impressive selectivity 
means that the biotransformation can be controlled and the target precursor for the IMOM reaction prepared 
selectively.  
 
 
 
 
 
 
Scheme 2. Conversion of 1a to 2a after 8 minutes incubation with LK-ADH, followed by IMOMR to give THP 3a. 1-hour incubation with 
LK-ADH afforded diol 4a. 
 
 Substrates 1b-c were then used to further probe the scope of the methodology. As the enone substituent on 
these two substrates is relatively large compared to the methyl group in 1a, over reduction of the IMOM precursor 
to the corresponding diol was not expected to be an issue with this particular ADH, due to its preference for 
carbonyls with small substituents. Ketoenones 1b-c were converted to a mixture of 2b-c (major) and 3b-c (minor) 
after 20 minutes, in >99% conversion. Treatment with ethereal HCl catalysed the IMOMR and afforded 3b-c in 
98% yield and high cis:trans ratio1h (Table 1, entries 2 and 3). It was envisaged that selective reduction of the 
methyl ketone in 1e, followed by  IMOMR and hydrolysis would afford (-)-(R,R)-(cis-6-methyltetrahydropyran-2-
yl)acetic acid; the enantiomer of the natural product present in the glandular secretions of the civet cat,[8] whose 
synthesis has received considerable attention.[9] There have been a number of chemical routes reported for the 
preparation of 3e, including those exploiting an IMOMR,[9c,d] but many preparations rely on complex multi-step 
synthesis and harsh reaction conditions. Reaction of 1e with LK-ADH afforded 2e after 1 hour in >99% ee,[10] 
with no cyclised product observed. Subsequent treatment of 2e with sodium hydride led to efficient IMOMR, 
initially affording a 1:1 mixture of cis/trans isomers,[1h] which epimerised in solution over 48 hours to give a dr of 
91:9. Purification on silica gel provided solely cis-3e (dr >99:1) in 48% yield (Table, 1 entry 5), which was 
hydrolysed in aqueous LiOH, affording the target ()-(R,R)-(cis-6-methyltetrahydropyran-2-yl)acetic acid 
(compound I-3 in supporting information).  
 The corresponding tetrahydrofuran derivatives were also accessible using this approach. Substrates 1g-i 
were transformed in high conversion (87->99%) to THFs 3g-i in good yields (54-99%, Table 1, entries 7-9), but 
as expected,[2] epimerisation of these compounds was not achievable in either the acidic or basic conditions 
employed for the THPs 1a-e. Unlike the analogous THP derivative 1a that was synthesised using this approach, 
attempts to control the reduction and isolate the mono-reduced IMOM precursor 2f were unsuccessful and only 
the corresponding diol and starting material were observed after the biotransformation with LK-ADH. 
 
Table 1. Conversion of 1a-i to 3a-i using LK-ADH and subsequent acid/base-catalysed IMOMR. 
 
 
 
 
 
 
Entry Substrat
e 
R n Conv. 
(%)b) 
Yield (%)c) d.r. 
(cis:trans)d) 
1 1a Me 1 82 75e) 12:1 
2 1b tBu 1 >99 >99 8:1 
3 1c Ph 1 >99 >99 10:1 
4 1d CH2Ar 1 91 80e) 11:1 
5   1e f) EtO 1 >99 48e) >99:1 
6 1f Me 0 nag) na na 
7 1g tBu 0 87 77e) 1:1 
  8h) 1h Ph 0 >99 >99 1:1 
9 1ii) EtO 0 >99 54e) 1:1 
[a] Reaction conditions: (i) LK-ADH (100 µL resuspended whole cells from a 
100mg/mL wet cell resuspension), GDH (6U), substrate (50 mM), glucose (250 
mM), NADPH (0.01 mM), Tris.HCl buffer (100 mM, pH 7.5, 1 mL), 30 °C, 200 
rpm, 8 min for 1a, 60 min for 1b-i; (ii) HCl.Et2O (2 M), r.t., 1 h. [b] Conv. 
determined by NMR after cyclisation. [c] Combined isolated yield of both 
diastereoisomers. [d] cis/trans ratio determined by NMR spectroscopy (after 
purification for 2a, 2d, 2e, 2g, 2i). [e] Isolated yield after column 
chromatography. [f] oxa-Michael reaction carried out with NaH, r.t. 48 h. [g] Only 
the corresponding diol 4f and starting material 1f were recovered. [h] 10% 
MeOH added as co-solvent during biotransformation. [i] oxa-Michael reaction 
carried out with tBuOK, r.t., 1 h. 
 
 Having successfully demonstrated the feasibility and scope of the biocatalytic reduction/oxa-Michael reaction, 
the optimised conditions were applied in the chemo-enzymatic asymmetric total synthesis of brocaketone A 
analogue 3d. This natural product was recently isolated from Penicillium brocae MA-192.[11] Precursor ketoenone 
1d was synthesised in 35% yield over three steps, starting from commercially available acid 5 (Scheme 3). An 
LK-ADH-catalysed reduction followed by cyclisation afforded the brocaketone A derivative 3d (80% yield, 11:1 
dr). Asymmetric reduction of the carbonyl in 3d would provide a formal synthesis of the biologically active natural 
product, cladosporin.[12] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Chemo-enzymatic asymmetric total synthesis of brocaketone A analogue. a) N,O-Dimethylhydroxylamine hydrochloride, 1,1′-
carbonyldiimidazole, CH2Cl2, r.t., 24 h. b) CH2=CH2MgBr, THF, 0 oC – r.t., 2 h.  c) Hoveyda-Grubbs II, hept-6-en-2-one, CH2Cl2, 24 h. d) i) LK-
ADH, GDH, glucose, Tris.HCl, 30 oC, 200 rpm., 1 h ii) HCl.Et2O (2 M), r.t., 1 h. 
 
 In conclusion, we have developed a biocatalytic route for the asymmetric synthesis of tetrahydrofuran/pyran 
cyclic ethers, starting from easily accessible ketoenones. The strategy relies on an ADH-mediated asymmetric 
reduction of the ketoenone, followed by an intramolecular oxa-Michael reaction.  This novel approach has 
enabled the asymmetric synthesis of the enantiomer of the natural product (+)-(S,S)-(cis-6-
methyltetrahydropyran-2-yl)acetic acid as well as a derivative of recently reported brocaketone A, and represents 
an alternative chemoenzymatic approach for the stereoselective synthesis of cyclic ethers.  
Acknowledgements  
Research leading to these results has received funding from the EPSRC. The UK Catalysis Hub is kindly thanked for 
resources and support provided via our membership of the UK Catalysis Hub Consortium and funded by EPSRC 
(grants EP/K014706/2, EP/K014668/1, EP/K014854/1, EP/K014714/1 and EP/M013219/1). We are grateful to Prof. 
Wolfgang Kroutil from the University of Graz for supplying the ADH used in this study.  
Keywords: asymmetric reduction • alcohol dehydrogenase • biocatalysis • ketoenone • oxa-Michael reaction 
[1] a) C. F. Nising, S. Brase, Chem. Soc. Rev. 2008, 37, 1218-1228; b) C. F. Nising, S. Brase, Chem. Soc. Rev. 2012, 41, 988-
999; c) Q. Dai, N. K. Rana, J. C. –G. Zhao, Org. Lett. 2013, 15, 2922-2925; d) J. Hu, M. Bian, H. Ding, Tetrahedron Lett. 2016, 57, 5519-
5539; e) C. del Pozo, M. Sánchez-Roselló, J. Miró, Synthesis. 2017, 49, 2787-2802. For some other examples on asymmetric synthesis 
of THPs/THFs see: f) D. S. B. Daniels, A. L. Thompson, E. A. Anderson, Angew. Chem. Int. Ed. 2011, 50, 11506 –11510; Angew. Chem. 
2011, 123, 11708-11712 g) B. Mondal, M. Balha, S. Chandra Pan, Asian J. Org. Chem. 2018, 7, 1788–1792. For a further example of 
the asymmetric synthesis of THPs and a discussion on the mechanism of formation of cis/trans isomers under acidic and basic 
conditions see: h) H. Fuwa, N. Ichinokawa, K. Noto, M. Sasaki, J. Org. Chem. 2012, 77, 2588-2607. 
[2] a) G. S. Rao, N. Sudhakar, B. V. Rao, S. J. Basha, Tetrahedron: Asymmetry 2010, 21, 1963-1970; b) A. M. Shelke, V. Rawat, A. 
Sudalai, G. Suryavanshi, RSC Adv. 2014, 4, 49770-49774; c) H. Kim, Y. Park, J. Hong, Angew. Chem. 2009, 121, 7713-7717; d) J. H. 
Xie, L. C. Guo, X. H. Yang, L. X. Wang, Q. L. Zhou, Org. Lett. 2012, 14, 4758-4761; e) Q. Dai, N. K. Rana, J. C. Zhao, Org. Lett. 2013, 
15, 2922-2925; f) K. Sakurai, M. Sasaki, H. Fuwa, Angew. Chem. Int. Ed. 2018, 57, 5143-5146; Angew. Chem. 2018, 130, 5237-5240. 
[3] a) E. O’Reilly, N. Turner, Nat. Chem. Biol. 2013, 9, 285−288; b) A. Wells, H.-P. Meyer, ChemCatChem. 2014, 6, 918-920; c) A. P. 
Green, N. J. Turner, Perspect. Sci. 2016, 9, 42-48; d) M. Honig, P. Sondermann, N. J. Turner, E. M. Carreira, Angew. Chem. Int. Ed. 
2017, 56, 8942-8973; Angew. Chem. 2017, 129, 9068–9100; e) R. de Souza, L. S. M. Miranda, U. T. Bornscheuer, Chem. Eur. J. 2017, 
23, 12040-12063.  
[4] J. Ryan, M. Šiaučiulis, A. Gomm, B. Maciá, E. O'Reilly, V. Caprio, J. Am. Chem. Soc. 2016, 138, 15798-15800. 
[5] a) W. Kroutil, H. Mang, K. Edegger, K. Faber, Curr. Opin. Chem. Biol. 2004, 8, 120-126; b) C. Wandrey, Chem. Rec. 2004, 4, 254–
265; c) K. Goldberg, K. Schroer, S. Lütz, A. Liese, Appl. Microbiol. Biotechnol. 2007, 76, 237–248; d) G. W. Huisman, J. Liang, A.  
Krebber, Curr. Opin. Chem. Biol. 2010, 14, 122-129; e) F. Hollmann, I. W. C. E. Arends, D. Holtmann, Green Chem. 2011, 13, 2285–
2313. 
[6] a) W. Kroutil, H. Mang, K. Edegger, K. Faber, Adv. Synth. Catal. 2004, 346, 125-142; b) N. J. Turner, Curr. Opin. Chem. Biol. 2010, 
14, 115-121; c) D. Romano, R. Villa, F. Molinari, ChemCatChem, 2012, 4, 739-749; d) J. Liu, S. Wu, Z. Li, Curr. Opin. Chem. Biol. 2018, 
43, 77–86. 
[7] a) W. Hummel, Appl. Microbiol. Biotechnol. 1990, 34, 15-19; b) W. Hummel, Biotechnol. Lett. 1990, 12, 403-408; c) C. W. Bradshaw, 
W. Hummel, C. H. Wong, J. Org. Chem. 1992, 57, 1532-1536; d) J. Haberland, A. Kriegesmann, E. Wolfram, W. Hummel, A. Liese, 
Appl. Microbiol. Biotechnol. 2002, 58, 595-599; e) J. Haberland, W. Hummel, T. Daussmann, A. Liese, Org. Process Res. Dev. 2002, 6, 
458-462; f) A. Weckbecker, W. Hummel, Biocatal. Biotransform. 2006, 24, 380-389; g) M. Skoupi, C. Vaxelaire, C. Strohmann, M. 
Christmann, C. M. Niemeyer, Chem. Eur. J. 2015, 21, 8701-8705. 
[8] a) B. Maurer, A. Grieder, W. Thommen, Helv. Chim. Acta. 1979, 62, 44–47; b) B. Maurer, W. Thommen, Helv. Chim. Acta. 1979, 62, 
1096-1097.  
[9] a) D. J. Dixon, S. V. Ley, E. W. Tate, J. Chem. Soc., Perkin Trans. 1, 2000, 15, 2385-2394; b) M. Babjak, T. Gracza, Tetrahedron, 
2011, 67, 4980-4987; c) X. -H. Yang, K. Wang, S. –F. Zhu, J. -H. Xie, Q, -L. Zhou, J. Am. Chem. Soc. 2014, 136, 50, 17426-17429; d) 
Q. Ruan, L. Zhou, B. Breit, Catal. Commun. 2014, 53, 87–90; e) E. Keinan, K. K. Seth, R. J. Lamed, J. Am.Chem. Soc. 1986, 108, 
3474–3480; f) J. B. Jones, R. S. Hinks, Can. J. Chem., 1987, 65, 704–707; g) S. Mori, S. Iwamoto, S. Yamauchi, Biosci. Biotechnol. 
Biochem. 2006, 70, 712–717. 
[10] This reaction, as well as the biotransformation of the widely accepted substrate acetophenone, was initially used to det ermine the 
selectivity of the enzyme. In both cases, LK-ADH exclusively afforded the (R)-alcohol (see SI for details). Optical rotation values for 
compounds 3b-d and I-3 were then measured and compared to those reported in the literature. Other assignments were then based on 
this trend. 
[11] P. Zhang, L.-H. Meng, A. Mándi, X.-M. Li, T. Kurtán, B.-G. Wang, RSC Adv. 2015, 5, 39870-39877. 
[12] H. Zheng,
 
C. Zhao,
 
B. Fang,
 
P. Jing,
 
J. Yang,
 
X. Xie,
 
X. She, J. Org. Chem. 2012, 77, 5656-5663.  
 
 
 
 
COMMUNICATION 
  
 
 
 
Chemoenzymatric strategy: An alcohol dehydrogenase-triggered asymmetric reduction 
and subsequent intramolecular oxa-Michael reaction has been developed for the 
preparation of tetrahydropyrans (or oxanes) and tetrahydrofurans, in excellent conversion, 
yield and high enantiomeric and diastereomeric excess.   
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